biztrac. BETA
COMPANY REGISTER PROFILE
915459528 ORG. NO. 2026 ACCOUNTS 8 SECTIONS
Active UPDATED 03.10.2026
Wholesale of pharmaceutical and medical goods

ARTHREX NORWAY AS

Org. no. 915459528 Limited company (AS) Bærum Incorporated 2015 Active
Ownership graph ↗
Revenue 2026 NOK 131.0m
Operating profit NOK 14.5m
Equity NOK 35.1m
Incorporated 2015
Employees 27
Share capital NOK 16.3m

ARTHREX NORWAY AS is registered as a limited company in Bærum, Akershus with organisation number 915459528. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2015 and has 27 registered employees. Registered share capital is NOK 16.3m, divided into 1 shares. The company's stated purpose is: “Distribusjon av medisinsk utstyr samt det som naturlig står i forbindelse med dette.”. The most recent filed accounts, for the 2026 financial year, show NOK 131.0m in revenue and NOK 14.5m in operating profit.

Key figures · 2026

Revenue
NOK 131.0m
▲ +8 %
Operating profit
NOK 14.5m
▲ +229 %
Equity
NOK 35.1m
▲ +46 %
Est. value
NOK 55.8m

Financial health · 2026

Liquidity
2.29
Very good
Current assets ÷ current liabilities
Profitability
30.3%
Very good
Return on total assets
Solidity
64.5%
Very good
Equity as a share of total capital

Who owns ARTHREX NORWAY AS?

ARTHREX GMBH DE
ARTHREX NORWAY AS
NOK 131.0m rev. · NOK 14.5m profit

ARTHREX NORWAY AS has 1 registered shareholder:

  • ARTHREX GMBH 100.0%
All shareholders and roles →

Frequently asked questions about ARTHREX NORWAY AS

Who owns ARTHREX NORWAY AS?

ARTHREX GMBH is the largest registered owner, with 100.0%.

What is the revenue of ARTHREX NORWAY AS?

ARTHREX NORWAY AS had revenue of NOK 131.0m in 2026.

Where is ARTHREX NORWAY AS based?

ARTHREX NORWAY AS has its business address in Høvik.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.